Mazzucato, M;
Li, HL;
(2021)
A Market Shaping Approach for the Biopharmaceutical Industry: Governing Innovation Towards the Public Interest.
Journal of Law, Medicine & Ethics
, 49
(1)
pp. 39-49.
10.1017/jme.2021.8.
Preview |
Text
Mazzucato_A Market Shaping Approach for the Biopharmaceutical Industry_accepted manuscript.pdf Download (241kB) | Preview |
Abstract
Enhancing research and development and ensuring equitable pricing and access to cutting-edge treatments are both vital to a biopharmaceutical innovation system that works in the public interest. However, despite delivering numerous therapeutic advances, the existing system suffers from major problems: a lack of directionality to meet key needs, inefficient collaboration, high prices that fail to reflect the public contribution, and an overly-financialized business model.
| Type: | Article |
|---|---|
| Title: | A Market Shaping Approach for the Biopharmaceutical Industry: Governing Innovation Towards the Public Interest |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1017/jme.2021.8 |
| Publisher version: | https://doi.org/10.1017/jme.2021.8 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
| Keywords: | Pharmaceutical; Innovation; Pricing; Access; Governance |
| UCL classification: | UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of the Built Environment UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of the Built Environment > Inst for Innovation and Public Purpose UCL > Provost and Vice Provost Offices > UCL BEAMS UCL |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10142696 |
Archive Staff Only
 |
View Item |
